While analyzing the customer reviews of PrimeBiome, we primarily focused on whether customers have any major complaints ...

Randomised trial, 20-week treatment protocol plus 6-month follow up ...

Iantrek, Inc., a leader in bio-interventional ophthalmic surgery (BIOS), today announced it has surpassed 2,000 AlloFlo™ Uveo ...

The "Miracle in the Making" program is a testament to Faithful Fertility Collective's dedication to fostering hope and ...

In an industry filled with exaggerated claims and underwhelming results, Alpha Bites Gummies stands out for its transparency ...

Secondly, checking reported side effects (or the lack thereof) provides insight into safety and tolerance. ProstaVive is ...

The webcast of the fireside chats will be accessible in the investor section of 89bio’s website. A replay of the webcasts will be available for approximately 30 days following each conference.

Maxim Group LLC acted as sole book-running manager for the offering.

Agomab Therapeutics NV (“Agomab”) today announced late-breaking interim data from the ongoing STENOVA 1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal (GI)-restricted small molecule ...

The event, held at Cipriani 25 Broadway, celebrated NMDP’s mission and the impact on 7,994 lives through cell therapy in 2024 for patients battling blood cancers and blood disorders—the most ever ...

The grants described in this press release were approved by the Compensation Committee of the Amwell’s Board of Directors pursuant to the Amwell’s Inducement Plan and made in reliance on the ...

The inducement grant consisted of time-based restricted stock units (“RSUs”) for 69,600 shares of Intellia’s common stock, with one-third of such RSUs vesting on May 1, 2026, 2027 and 2028.